ERα-associated protein networks

Trends in Endocrinology and Metabolism

Volumn 22, Issue 4, 2011, Pages 124-129

  Schultz Norton, Jennifer R ^a   Ziegler, Yvonne S ^a   Nardulli, Ann M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APURINIC ENDONUCLEASE 1; CYCLINE; DNA; ENDONUCLEASE; ESTROGEN RECEPTOR ALPHA; FLAP ENDONUCLEASE; HIGH MOBILITY GROUP PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN DISULFIDE ISOMERASE; REGULATOR PROTEIN; SUPEROXIDE DISMUTASE; THIOREDOXIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

CELL FATE; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; GENOMICS; HUMAN; NEOPLASM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; DNA REPAIR; ESTROGEN RECEPTOR ALPHA; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS;

EID: 79953164697     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2010.11.005     Document Type: Review

References (88)

1. Beato M., et al. Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857.
2. Wood J.R., et al. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol. Cell Biol. 1998, 18:1927-1934.
3. Loven M.A., et al. Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol. Cell Endocrinol. 2001, 181:151-163.
4. Wood J.R., et al. Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol. Endocrinol. 2001, 15:1114-1126.
5. Yi P., et al. The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. Mol. Endocrinol. 2002, 16:674-693.
6. Hall J.M., et al. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 2002, 16:469-486.
7. Klinge C.M., et al. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J. Mol. Endocrinol. 2004, 33:387-410.
8. Horwitz K.B., et al. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 1996, 10:1167-1177.
9. Smith C.L., O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 2004, 25:45-71.
10. Schultz-Norton J.R., et al. Isolation of proteins associated with the DNA-bound estrogen receptor alpha. Methods Mol. Biol. 2009, 590:209-221.
11. Schultz-Norton J.R., et al. Isolation of novel coregulatory protein networks associated with DNA-bound estrogen receptor alpha. BMC Mol. Biol. 2008, 9:97.
12. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 1996, 6596407090:135-167.
13. Robertson A.B., et al. DNA repair in mammalian cells. Base excision repair: the long and short of it. Cell Mol. Life Sci. 2009, 66:981-993.
14. Likhite V.S., et al. Interaction of estrogen receptor alpha with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J. Biol. Chem. 2004, 279:16875-16882.
15. Schultz-Norton J.R., et al. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol. Endocrinol. 2006, 20:1982-1995.
16. Schultz-Norton J.R., et al. The deoxyribonucleic acid repair protein flap endonuclease-1 modulates estrogen-responsive gene expression. Mol. Endocrinol. 2007, 21:1569-1580.
17. Curtis C.D., et al. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression. Mol. Endocrinol. 2009, 23:1346-1359.
18. Okuwaki M., Nagata K. Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template. J. Biol. Chem. 1998, 273:34511-34518.
19. Fan Z., et al. HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A. Mol. Cell Biol. 2002, 22:2810-2820.
20. Seo S.B., et al. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001, 104:119-130.
21. Lieberman J., Fan Z. Nuclear war: the granzyme A-bomb. Curr. Opin. Immunol. 2003, 15:553-559.
22. Beresford P.J., et al. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J. Biol. Chem. 2001, 276:43285-43293.
23. Cervoni N., et al. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J. Biol. Chem. 2002, 277:25026-25031.
24. Beresford P.J., et al. Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9285-9990.
25. Fan Z., et al. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003, 112:659-672.
26. Fan Z., et al. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat. Immunol. 2003, 4:145-153.
27. Boonyaratanakornkit V., et al. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell Biol. 1998, 18:4471-4487.
28. Romine L.E., et al. The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol. Endocrinol. 1998, 12:664-674.
29. Zhang C.C., et al. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol. Endocrinol. 1999, 13:632-643.
30. Senkus-Melvin, V. and Edwards, D.P. (2001) Expression and purification of recombinant human progesterone receptor in baculovirus and bacterial systems. In Methods in Molecular Biology (Vol. 176, Pt II), (Lieberman, B.A., ed.), pp. 39-54, Humana Press.
31. Loven M.A., et al. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation. Mol. Endocrinol. 2003, 17:67-78.
32. Loven M.A., et al. A novel estrogen receptor alpha-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription. Mol. Endocrinol. 2004, 18:2649-2659.
33. Curtis C.D., et al. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Cancer Res. 2007, 67:10600-10607.
34. Schroder E., Ponting C.P. Evidence that peroxiredoxins are novel members of the thioredoxin fold superfamily. Protein Sci. 1998, 7:2465-2468.
35. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31:1287-1312.
36. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267:6102-6109.
37. Webster K.A., et al. Oxidation of zinc finger transcription factors: physiological consequences. Antioxid. Redox Signal 2001, 3:535-548.
38. Wang C.C., Tsou C.L. Protein disulfide isomerase is both an enzyme and a chaperone. FASEB J. 1993, 7:1515-1517.
39. Quan H., et al. Independence of the chaperone activity of protein disulfide isomerase from its thioredoxin-like active site. J. Biol. Chem. 1995, 270:17078-17080.
40. Klappa P., et al. The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J. 1998, 17:927-935.
41. Wilkinson B., Gilbert H.F. Protein disulfide isomerase. Biochim. Biophys. Acta 2004, 1699:35-44.
42. Rao A.K., et al. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. J. Mol. Endocrinol. 2009, 43:251-261.
43. Rao A.K., et al. Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol. Endocrinol. 2008, 22:1113-1124.
44. Lundstrom J., Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J. Biol. Chem. 1990, 265:9114-9120.
45. Atkin J.D., et al. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J. Biol. Chem. 2006, 281:30152-30165.
46. Cheung P.Y., et al. Refolding of thioredoxin reductase assisted by groEL and PDI. Biochem. Biophys. Res. Commun. 1999, 255:17-22.
47. Whittal R.M., et al. Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding. Biochemistry (N Y) 2000, 39:8406-8417.
48. Hayashi S., et al. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 1997, 25:4035-4040.
49. Xanthoudakis S., Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 1992, 11:653-665.
50. Xanthoudakis S., et al. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 1992, 11:3323-3335.
51. Jayaraman L., et al. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 1997, 11:558-570.
52. Lando D., et al. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J. Biol. Chem. 2000, 275:4618-4627.
53. Evans A.R., et al. Going APE over ref-1. Mutat. Res. 2000, 461:83-108.
54. Webster N.J.G., et al. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 1988, 54:199-207.
55. Baldwin M.A., Benz C.C. Redox control of zinc finger proteins. Meth. Enzymol. 2002, 353:54-69.
56. Kim M.Y., et al. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol. 2006, 20:1479-1493.
57. Kutney S.N., et al. A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J. Biol. Chem. 2004, 279:30850-30855.
58. Naryzhny S.N., Lee H. The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function. J. Biol. Chem. 2004, 279:20194-20199.
59. Seo S.B., et al. Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J. Biol. Chem. 2002, 277:14005-14010.
60. Brown C.E., et al. The many HATs of transcription coactivators. Trends Biochem. Sci. 2000, 25:15-19.
61. Vo N., et al. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol. Cell Biol. 2001, 21:6181-6188.
62. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 6420299365:435-459.
63. Svejstrup J.Q. Mechanisms of transcription-coupled DNA repair. Nat. Rev. Mol. Cell Biol. 2002, 3:21-29.
64. Mellon I., et al. Preferential DNA repair of an active gene in human cells. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:8878-8882.
65. Mellon I., et al. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 1987, 51:241-249.
66. Morrison A.J., Shen X. Chromatin modifications in DNA repair. Results Probl. Cell Differ. 2006, 41:109-125.
67. Wuebbles R.D., Jones P.L. DNA repair in a chromatin environment. Cell Mol. Life Sci. 2004, 61:2148-2153.
68. Chen D., et al. T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha. J. Biol. Chem. 2003, 278:38586-38592.
69. Teo A.K., et al. The modified human DNA repair enzyme O(6)-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage. Mol. Cell Biol. 2001, 21:7105-7114.
70. Ju B.G., et al. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 2006, 312:1798-1802.
71. Crowe D.L., Lee M.K. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines. Breast Cancer Res. 2006, 8:R1.
72. Coquerelle T., et al. Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents: a case of imbalanced DNA repair. Mutat. Res. 1995, 336:9-17.
73. Aaltomaa S., et al. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer. Anticancer Res. 1993, 13:533-538.
74. Malkas L.H., et al. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19472-19477.
75. Kucherlapati M., et al. Haploinsufficiency of flap endonuclease (Fen1) leads to rapid tumor progression. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9924-9929.
76. Giancotti F.R., et al. Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies. Gynecol. Oncol. 1990, 37:24-28.
77. Curtis C.D., et al. Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues. BMC Cancer 2010, 10:9.
78. Hoelz D.J., et al. The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics 2006, 6:4808-4816.
79. Kadkol S.S., et al. Expression of pp32 gene family members in breast cancer. Breast Cancer Res. Treat. 2001, 68:65-73.
80. Bai J., et al. Tumor suppression and potentiation by manipulation of pp32 expression. Oncogene 2001, 20:2153-2260.
81. Ouatas T., et al. Basic and translational advances in cancer metastasis: Nm23. J. Bioenerg. Biomembr. 2003, 35:73-79.
82. Hartsough M.T., Steeg P.S. Nm23/nucleoside diphosphate kinase in human cancers. J. Bioenerg. Biomembr. 2000, 32:301-308.
83. Tokunaga Y., et al. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer 1993, 55:66-71.
84. Fishel M.L., et al. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst.) 2008, 7:177-186.
85. Bianchi M.S., et al. Superoxide dismutase activity and superoxide dismutase-1 gene methylation in normal and tumoral human breast tissues. Cancer Genet. Cytogenet. 1992, 59:26-29.
86. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
87. Schultz-Norton J.R., et al. Interaction of estrogen receptor alpha with proliferating cell nuclear antigen. Nucleic Acids Res. 2007, 35:5028-5038.
88. Das D., et al. High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Mol. Endocrinol. 2004, 18:2616-2632.